Many reports suggest that podoplanin promotes tumor and metastasis; however, there are several controversial reports that podoplanin expression in lung SCC correlates with lower incidence of lymph node metastasis and good prognosis [64–66]. This evidence concerns the gene PDPN and metastatic malignant neoplasm in the lymph nodes.